Making the change through acute medical team education: Inpatient risk assessment of stable pulmonary embolism cases at high risk of deterioration

The safety of optimal management of acute sub-massive or massive pulmonary embolism (PE) with thrombolytic agents remains unclear.[1][1] Thrombolytic agents reduce mortality and improve right ventricular function, but increase the risk of major haemorrhage and stroke.[2–4][2] Our project reviews